The role of real world evidence to support US FDA and TGA registrations

 

“Regulatory agencies worldwide are considering how they may incorporate RWE into their decision-making processes for new medicine applications.” - Jennifer Hare, Novotech’s Senior Consultant, recently shared more insight on how the use of RWE to support new medicine registrations in Australia is evolving.